We also conduct a metabolomics analysis subsequent to the forced expression of LYRM2 in HCC cells, which demonstrated an increase in glycolytic metabolites and a decrease in metabolites associated with TCA cycle upon LYRM2 overexpression (Figure 5D). Here, LYRM2 is linked to hepatocellular carcinoma.